Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

Purinergic Library

Preferred format:
Desirable size of the custom library selection:
  • Mg
  • uMol

ChemDiv’s  Purinergic library contains 3,500 compounds.

Purinergic receptors are involved in many physiological and pathological conditions of cells. Adenosine 5’-triphosphate (ATP) is a cotransmitter with classical transmitters in both the peripheral and central nervous systems. In addition, purines are powerful extracellular messengers to non-neuronal cells, including secretory, exocrine and endocrine, endothelial, immune, musculo-skeletal and inflammatory cells. Purinergic signaling alterations may occur due to abnormal receptor expression or extracellular nucleotide levels. Synthetic modulators for receptors and enzymes involved in the purinergic signaling machinery have been developing. [1]

In the gastrointestinal tract, purine nucleosides and nucleotides modulate motor, secretory, and sensory functions and dysfunctions. Synthetic purinergic receptor/enzyme modulators help to restore normal motor, secretory, and sensory functions. Currently, potent and selective purinergic signaling modulators as novel therapeutic tools for gastrointestinal diseases are developed. [2]

Moreover, there was recognition of the use of P1 receptor agonists for the treatment of supraventricular tachycardia and A2A receptor antagonists are promising for the treatment of Parkinson’s disease. Clopidogrel, a P2Y12 antagonist, is widely used for the treatment of thrombosis and stroke, blocking P2Y12 receptor-mediated platelet aggregation. Other investigations are in progress for the use of purinergic agents for the treatment of osteoporosis, myocardial infarction, epilepsy, atherosclerosis, depression, autism, diabetes, and cancer. [1]

[1]         G. Burnstock, “Purinergic signalling: Therapeutic developments,” Frontiers in Pharmacology, vol. 8. Frontiers Media S.A., Sep. 01, 2017, doi: 10.3389/fphar.2017.00661.

[2]         D. Dal Ben et al., “Approaches for designing and discovering purinergic drugs for gastrointestinal diseases,” Expert Opin. Drug Discov., vol. 15, no. 6, pp. 687–703, 2020, doi: 10.1080/17460441.2020.1743673.

0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies